Takeda Pharmaceutical Co. (TAK)

Last Closing Price: 14.19 (2024-03-27)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Takeda Pharmaceutical Co. (TAK) had Revenue of $7.56B for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
Revenue
$7.56B
$718.90M
$2.58B
$4.98B
$6.84B
$713.41M
$-296.85M
$416.57M
$416.57M
$719.14M
$719.14M
$719.14M
$719.14M
$713.41M
$1.95B
3.14B
3.17B
$0.23
$0.23
Balance Sheet Financials
$16.52B
$12.52B
$80.20B
$96.72B
$15.52B
$29.20B
$35.35B
$50.87B
$45.85B
$-16.77B
$45.85B
3.16B
Cash Flow Statement Financials
$2.98B
$-2.74B
$-2.01B
$3.63B
$1.96B
$-1.67B
$358.24M
$-1.89B
--
Fundamental Metrics & Ratios
1.06
--
--
0.39
0.69
65.85%
9.44%
9.44%
--
5.51%
9.51%
$2.15B
--
--
--
0.08
0.32
1.50
60.19
1.57%
-4.29%
0.74%
0.96%
$14.49
$0.68
$0.94